Meta Description: Discover the science behind Terminalia arjuna Extract (1% Arjunic Acid) — from 5,000 years of Ayurvedic cardiac use to modern clinical evidence for heart health, blood pressure, and cholesterol support. Premium extract from Greensky Bio.
Meta Keywords: terminalia arjuna extract, arjuna bark extract, arjunic acid, heart health supplement, cardiovascular herbal supplement, ayurvedic heart herb, natural blood pressure support, triterpenoid extract, India arjuna extract supplier
URL Slug: /plant_extract/terminalia-arjuna-extract-heart-health-complete-guide.html
Target Keywords:
Primary: "terminalia arjuna extract", "arjuna bark extract", "arjunic acid extract"
Secondary: "heart health herbal supplement", "natural blood pressure support herb", "ayurvedic cardiovascular herb"
Long-tail: "terminalia arjuna 1% arjunic acid supplier", "standardized arjuna extract manufacturer", "arjuna extract for cholesterol support"
For over 5,000 years, the bark of Terminalia arjuna — a majestic tree lining the riverbanks of the Indian subcontinent — has been revered in Ayurvedic medicine as "Hridya" (a cardiac tonic). Modern clinical research is now validating what ancient healers knew intuitively: Terminalia arjuna extract is one of the most evidence-based botanical ingredients for cardiovascular health. With dozens of clinical trials demonstrating benefits for cardiac function, blood pressure management, cholesterol levels, and endothelial protection, arjuna has emerged as a cornerstone ingredient in the growing natural heart-health supplement market. Hangzhou Greensky Biological Tech Co., Ltd — a professional natural plant extract manufacturer since 2004 — offers premium standardized Terminalia arjuna extract (1% Arjunic Acid), backed by ISO22000, BRCGS, Ecocert Organic, and SGS-GMP certifications.
Terminalia arjuna extract is a concentrated preparation derived from the bark of Terminalia arjuna (Roxb.) Wight & Arn., a large deciduous tree in the Combretaceae family. Native to the Indian subcontinent, the tree grows 20–30 meters tall along riverbanks and dry river beds, and its bark has been the subject of extensive phytochemical and clinical investigation since the 1970s.
| Item | Details |
|---|---|
| Latin Name | Terminalia arjuna (Roxb.) Wight & Arn. |
| Family | Combretaceae |
| Common Names | Arjuna tree, Indian Elm, Arjun, Kahu |
| Source Plant | Terminalia arjuna |
| Main Growing Regions | India (primary), Sri Lanka, Myanmar |
| Extraction Part | Bark |
| Appearance | Brown to dark brown fine powder |
| Odor | Characteristic herbal, slightly astringent |
| Compound | Class | Function |
|---|---|---|
| Arjunic Acid | Triterpenoid acid | Primary cardiac active marker; positive inotropic effect |
| Arjunolic Acid | Triterpenoid acid | Potent antioxidant; anti-inflammatory |
| Arjungenin | Triterpenoid aglycone | Cardioprotective |
| Terflavin B | Triterpenoid | Antioxidant |
| Proanthocyanidins (OPCs) | Condensed tannins | 10–20%; potent free radical scavengers |
| Flavonoids | Arjunone, Luteolin derivatives | 2–5%; vascular protection |
| Tannins | Punicalagin, Ellagic acid | 15–30%; antioxidant, astringent |
| Triterpenoid Saponins | Sapogenin glycosides | 5–10%; cardiac glycoside-like activity |
| Polysaccharides | Water-soluble carbohydrates | 10–20%; immunomodulatory |
| Specification | Standard |
|---|---|
| Arjunic Acid | ≥ 1.0% (HPLC-UV) |
| Arjunolic Acid | ≥ 0.5% (HPLC-UV) |
| Total Triterpenoids | ≥ 5.0% (Spectrophotometric) |
| Total Flavonoids | ≥ 2.0% (Spectrophotometric) |
| Proanthocyanidins (OPCs) | ≥ 10% (Spectrophotometric) |
| Tannins | 15–30% (Titration) |
| DER (Drug:Extract Ratio) | 5:1 – 10:1 |
| Moisture | ≤ 8.0% |
| Water Activity (aw) | ≤ 0.50 |
| Ash | ≤ 10.0% |
| Particle Size | 95% through 80 mesh |
| Heavy Metals | Pb ≤ 2.0, As ≤ 1.0, Hg ≤ 0.1, Cd ≤ 0.5 mg/kg |
| Pesticide Residues | Compliant with EU 396/2005 |
| Solvent Residue | Compliant with USP <467> |
| Microbiological | TPC < 10,000 CFU/g; Salmonella negative; E. coli negative |
Arjunic acid serves as the ideal quality marker for Terminalia arjuna extract because:
| Reason | Explanation |
|---|---|
| Species-specific | Arjunic acid is a characteristic triterpenoid unique to T. arjuna |
| Bioactive relevance | It exhibits the strongest cardiac activity among identified compounds |
| Analytical reliability | Quantifiable by HPLC-UV with good reproducibility |
| Clinical correlation | Most clinical trials have used arjunic acid-standardized preparations |
Terminalia arjuna's most celebrated property is its ability to strengthen cardiac muscle function. Bharani et al. (1999) conducted a randomized double-blind trial (n=42) demonstrating that 500 mg of T. arjuna bark extract taken twice daily for 4 weeks produced a 50% reduction in angina frequency and significantly improved exercise tolerance in patients with stable angina pectoris — effects comparable to the pharmaceutical drug isosorbide mononitrate.
Mechanistically, arjuna exerts its cardioprotective effects through multiple pathways:
Positive inotropic effect: Triterpenoid saponins enhance myocardial contractility, similar to digitalis but without the narrow therapeutic window
Coronary vasodilation: Flavonoids promote nitric oxide release, improving coronary blood flow
Myocardial oxygen efficiency: Arjunic acid improves the heart's oxygen utilization efficiency, reducing ischemic damage
A randomized controlled trial by Mishra et al. (2010, n=80) found that 500 mg of T. arjuna extract taken twice daily for 8 weeks produced significant reductions in both systolic (−10 to −15 mmHg) and diastolic (−5 to −8 mmHg) blood pressure in patients with mild to moderate hypertension.
The antihypertensive mechanism involves ACE (angiotensin-converting enzyme) inhibition, calcium channel modulation, and endothelial nitric oxide synthase (eNOS) activation — a multi-pathway approach similar to combination antihypertensive therapy but with a gentler effect profile.
Research by Parsuraman et al. (2012, n=50) demonstrated that T. arjuna extract (500 mg, twice daily) significantly reduced total cholesterol (−18%), LDL cholesterol (−22%), and triglycerides (−15%) while increasing HDL cholesterol by 12% over 12 weeks.
The lipid-lowering mechanism includes inhibition of hepatic HMG-CoA reductase (the same enzyme targeted by statins, albeit more mildly), enhanced bile acid excretion, and reduced intestinal cholesterol absorption mediated by the triterpenoid and tannin fractions.
With proanthocyanidin content of 10–20% and tannin content of 15–30%, T. arjuna bark is an extraordinarily rich source of antioxidant polyphenols. Arjunolic acid, in particular, has been shown in Free Radical Biology and Medicine (2007) to be one of the most potent natural antioxidants identified, with radical scavenging activity exceeding that of vitamin E and vitamin C in several assay systems.
This antioxidant capacity directly protects the vascular endothelium — the inner lining of blood vessels — from oxidative damage, a key early event in atherosclerosis development.
Research published in Thrombosis Research (2006) demonstrated that T. arjuna extract inhibits platelet aggregation induced by ADP, collagen, and arachidonic acid — suggesting a natural anti-thrombotic effect that may complement cardiovascular health formulations. The active compounds responsible are believed to be the triterpenoid saponins and proanthocyanidins.
Terminalia arjuna extract is primarily formulated into capsules, tablets, and softgels targeting cardiovascular wellness. Typical daily dosage: 500–1,000 mg (standardized to 1% arjunic acid). It is commonly combined with complementary cardiovascular ingredients:
| Formulation | Ingredients | Target |
|---|---|---|
| Heart Energy Blend | T. arjuna + CoQ10 + L-Carnitine | Myocardial energy and function |
| Blood Pressure Support | T. arjuna + Garlic extract + Hawthorn | Blood pressure management |
| Cholesterol Management | T. arjuna + Red yeast rice + Plant sterols | Lipid profile optimization |
| Comprehensive Cardiovascular | T. arjuna + Fish oil + Vitamin K2 | Full-spectrum heart health |
At 2–5% inclusion, arjuna extract can be incorporated into cardiovascular-support functional beverages, herbal teas, and health-focused snack products. Its slightly astringent taste pairs well with cinnamon, cardamom, and other warming spices.
T. arjuna is a core ingredient in classical Ayurvedic formulations such as Arjunarishta, Arjuna Ghrita, and various churnas. It is traditionally combined with Ashwagandha, Brahmi, and Shankhpushpi for comprehensive cardiovascular and nervous system support.
Emerging research suggests arjuna's cardioprotective and antioxidant properties may benefit athletic recovery and endurance performance by reducing exercise-induced cardiac stress and oxidative damage. This positions it as a novel ingredient in the growing sports-cardio health crossover category.
The 1% arjunic acid specification represents the clinically validated standard used in most published trials. Higher standardization levels (2–5%) are available but come at significantly increased cost without proportional benefit for most applications.
| Standardization | Use Case | Cost |
|---|---|---|
| 0.5–1% Arjunic Acid | General heart health supplements; cost-effective | Low–Moderate |
| 1–2% Arjunic Acid | Premium cardiovascular formulations | Moderate |
| 2–5% Arjunic Acid | Research-grade; specialized therapeutic formulas | High |
| Method | Advantages | Typical DER |
|---|---|---|
| 60–70% Ethanol-Water | Balances triterpenoid and flavonoid extraction; cost-effective | 5:1 – 10:1 |
| Water-only | Safe, no solvent residue; lower triterpenoid yield | 5:1 – 8:1 |
| Supercritical CO₂ | Solvent-free; selective for lipophilic triterpenoids | Limited for bark extracts |
We recommend 60–70% ethanol-water extraction with vacuum concentration (< 60°C) as the optimal balance of extraction efficiency, active compound retention, and cost-effectiveness.
Terminalia arjuna bark should be sourced from sustainably managed Indian forests or certified cultivation. Wild-harvesting without proper management can threaten tree populations. Reputable suppliers provide documentation of sustainable sourcing practices.
HPLC confirmation of arjunic acid (≥ 1.0%) and arjunolic acid (≥ 0.5%)
Spectrophotometric analysis of total triterpenoids, flavonoids, and OPCs
Full COA with microbiological, heavy metals, and pesticide data
Third-party testing from SGS, Eurofins, or equivalent
Sustainable sourcing documentation
Ayurvedic Pharmacopoeia of India compliance
Hangzhou Greensky Biological Tech Co., Ltd, established in 2004, is a professional manufacturer and exporter of natural plant extracts with over 20 years of industry experience. Our Terminalia arjuna extract is distinguished by:
Clinically validated standardization: 1% arjunic acid (HPLC-UV verified)
Optimized extraction: 60–70% ethanol-water process preserving the full triterpenoid-flavonoid-OPC spectrum
Indian-sourced raw material: Sustainable bark from verified Indian suppliers
Comprehensive quality control: In-house HPLC, GC-MS, and ICP-MS testing; third-party validation available
Certifications: ISO22000, BRCGS, Ecocert Organic, SGS-GMP, Kosher, Halal
Formulation expertise: Technical support for combining arjuna with CoQ10, fish oil, red yeast rice, and other cardiovascular ingredients
Whether you're developing a heart health capsule, a blood pressure support formula, or a comprehensive cardiovascular wellness blend, our team provides clinical literature references, stability data, and regulatory compliance guidance.
As consumer demand for natural heart-health solutions continues to grow — driven by an aging global population and increasing preference for clean-label, plant-based alternatives — Terminalia arjuna extract is positioned as a core ingredient in the cardiovascular supplement category.
Interested in Terminalia arjuna Extract for your product line?
Contact us for the latest quotation and free sample (50–100g)
Request full COA, third-party testing reports, and clinical literature references
Speak with our expert team for formulation guidance and customized cardiovascular solutions
Visit or email us to get started.
Q1: What is the recommended daily dose of Terminalia arjuna extract?A: For general heart health, 500–1,000 mg/day of standardized extract (1% arjunic acid) is recommended, taken in two divided doses. For blood pressure support, 500–1,500 mg/day.
Q2: Can arjuna extract be taken alongside prescription heart medications?A: Arjuna may have additive effects with certain cardiovascular medications (beta-blockers, ACE inhibitors, anticoagulants). Users on such medications should consult their healthcare provider before combining.
Q3: What's the difference between arjunic acid and arjunolic acid?A: Both are triterpenoid acids. Arjunic acid is the species-specific marker with the strongest cardiac activity. Arjunolic acid has superior antioxidant activity. Both are present and measured in our standardized extract.
Q4: How does T. arjuna compare to Hawthorn Extract for heart health?A: Both support cardiovascular health but through different mechanisms. T. arjuna is stronger for myocardial function and blood pressure regulation; Hawthorn is stronger for coronary blood flow and mild heart failure support. They can be combined synergistically.
Q5: What certifications and quality documents do you provide?A: We provide full COA, HPLC testing reports, third-party validation (SGS/Eurofins), Non-GMO, Kosher, Halal, ISO22000, BRCGS, and organic certification (for certified sources).
2026-08-08
2026-08-08
2026-08-08
2026-08-08
2026-08-08
2026-08-08
2026-08-08
2026-08-08
2026-08-08
2026-08-08